Evidence map›Paper›PMID 37334615›Full record

ArticleJournal of Parkinson's disease2023

What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP).

Connie Marras, Lakshmi Arbatti, Abhishek Hosamath, Amy Amara, Karen E Anderson, Lana M Chahine, Shirley Eberly, Dan Kinel, Sneha Mantri, Soania Mathur and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. What medicines do people with Parkinson's disease want?Journal of Parkinson's disease · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Connie MarrasEdmond J Safra Program in Parkinson's Disease, University Health Network, University of Toronto, Toronto, Canada.
Lakshmi ArbattiGrey Matter Technologies, a Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA.
Abhishek HosamathGrey Matter Technologies, a Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA.
Amy AmaraDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Karen E AndersonDepartments of Psychiatry and Neurology, Georgetown University, Washington DC, USA.
Lana M ChahineDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
Shirley EberlyDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.
Dan KinelDepartment of Neurology, University of Rochester, Rochester NY, USA.
Sneha MantriDepartment of Neurology, Duke University, Durham, NC, USA.
Soania MathurPD Avengers, Toronto, Canada.
David OakesDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.
Jennifer L PurksDepartment of Neurology, University of Rochester, Rochester NY, USA.
David G StandaertPD Avengers, Toronto, Canada.
Caroline M TannerDepartment of Neurology, Weill Institute for Neurosciences, University of California - San Francisco, San Francisco, CA, USA.
Daniel WeintraubDepartments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Ira ShoulsonGrey Matter Technologies, a Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA.
University of Rochester · USDuke University · USGeorgetown University · USUniversity Health Network · CAUniversity of California, San Francisco · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Pennsylvania · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFree-text, verbatim replies in the words of people with Parkinson's disease (PD) have the potential to provide unvarnished information about their feelings and experiences. Challenges of processing such data on a large scale are a barrier to analyzing verbatim data collection in large cohorts.

objectiveTo develop a method for curating responses from the Parkinson's Disease Patient Report of Problems (PD-PROP), open-ended questions that asks people with PD to report their most bothersome problems and associated functional consequences.

methodsHuman curation, natural language processing, and machine learning were used to develop an algorithm to convert verbatim responses to classified symptoms. Nine curators including clinicians, people with PD, and a non-clinician PD expert classified a sample of responses as reporting each symptom or not. Responses to the PD-PROP were collected within the Fox Insight cohort study.

resultsApproximately 3,500 PD-PROP responses were curated by a human team. Subsequently, approximately 1,500 responses were used in the validation phase; median age of respondents was 67 years, 55% were men and median years since PD diagnosis was 3 years. 168,260 verbatim responses were classified by machine. Accuracy of machine classification was 95% on a held-out test set. 65 symptoms were grouped into 14 domains. The most frequently reported symptoms at first report were tremor (by 46% of respondents), gait and balance problems (>39%), and pain/discomfort (33%).

conclusionA human-in-the-loop method of curation provides both accuracy and efficiency, permitting a clinically useful analysis of large datasets of verbatim reports about the problems that bother PD patients.

Indexed as

Parkinson DiseaseAgedAlgorithmsCohort StudiesFemaleHumansMachine LearningMaleTremormachine learningmeasurementParkinson’s diseasePatient-reported outcome

Identifiers

PMID37334615
PMCPMC10473108
OpenAlexW4380631541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.